Overview
Runchun Lu practices in Beijing, China. Lu is rated as an Advanced expert by MediFind in the treatment of Hemangioblastoma. Their top areas of expertise are Hemangioblastoma, Von Hippel-Lindau (VHL) Syndrome, Hemangioma, and Hypothalamic Tumor.
Their clinical research consists of co-authoring 16 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 5 articles in the study of Hemangioblastoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- HemangioblastomaLu isAdvanced. Learn about Hemangioblastoma.
- HemangiomaLu isAdvanced. Learn about Hemangioma.
- Von Hippel-Lindau (VHL) Syndrome
- Experienced
- Brain TumorLu isExperienced. Learn about Brain Tumor.
- HydrocephalusLu isExperienced. Learn about Hydrocephalus.
- Hypothalamic TumorLu isExperienced. Learn about Hypothalamic Tumor.
- Parathyroid AdenomaLu isExperienced. Learn about Parathyroid Adenoma.
- Parathyroid CancerLu isExperienced. Learn about Parathyroid Cancer.
- Pituitary TumorLu isExperienced. Learn about Pituitary Tumor.